Susan Horvath

Overview

Susan Horvath received an average of $458K in total compensation, including $250K in salary, at Panbela Therapeutics from 2019 to 2021.

Source: SEC filings on April 29, 2022 and April 15, 2021.

Related executives

We found two more executives who work or worked at Panbela Therapeutics.

Jennifer Simpson

Panbela Therapeutics

Chief Executive Officer

Michael Cullen

Panbela Therapeutics

Chairman

News

You may also like